Steve Duffy, Author at Renal and Urology News

Steve Duffy

Digital Content Editor

All articles by Steve Duffy

LDL-C Targets for Preexisting Heart Disease

FDA Approves First-in-Class Cholesterol Lowering Therapy

The Food and Drug Administration (FDA) has approved Nexletol (bempedoic acid; Esperion) as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD) who require additional lowering of low-density lipoprotein cholesterol (LDL-C). Nexletol is a first-in-class adenosine triphosphate-citrate lyase (ACL)…

urine sample

Contepo NDA for Complicated UTI Resubmitted

Fosfomycin is a novel, epoxide intravenous antibiotic with a broad spectrum of Gram-negative and Gram-positive activity, including activity against multi-drug resistant (MDR) strains such as extended spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.

Next post in Uncategorized